Grifols (GRFS)
(Real Time Quote from BATS)
$10.86 USD
+0.08 (0.74%)
Updated Aug 4, 2025 11:32 AM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
NA
Time: -- |
9/2025 | $0.27 | 0.00% |
Earnings Summary
For their last quarter, Grifols (GRFS) reported earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.23 per share. This reflects a negative earnings surprise of 17.39%. Look out for GRFS's next earnings release expected on .
Earnings History
Price & Consensus
Zacks News for GRFS
Will Strong Asceniv Sales Drive ADMA Biologics Further?
GRFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?
ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold?
Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know
GRFS FAQs
Based on past history, Zacks believes Grifols, S.A. (GRFS) will report their next quarter earnings on . For the next earning release, we expect the company to report earnings of 0.27 per share, reflecting a year-over-year increase of .
Based on past history, Zacks believes Grifols, S.A. (GRFS) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on .
The Zacks Consensus Estimate for Grifols, S.A. (GRFS) for the quarter ending September 2025 is $0.27 a share. We expect Grifols, S.A. (GRFS) to report earnings in line with the consensus estimate of $0.27 per share
In the earnings report for the quarter ending in June 2024, Grifols, S.A. (GRFS) announced earnings of $0.02 per share versus the Zacks Consensus Estimate of $0.23 per share, representing a surprise of -91.30%.